Perrigo Co has the GF Score of 44, which implies that the company
might have
Worst future performance potential, or not enough data.
The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.
GF Score takes following five key aspects into consideration:
Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.
Based on research and backtesting result, GuruFocus believes Perrigo Co
might have
Worst future performance potential, or not enough data.
Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.
Perrigo Co (MEX:PRGON) GF Score Explanation
Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:
GF Score
Performance Potential and All-in-One Screener Examples (1)
(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.
Perrigo Co GF Score Related Terms
MEX:PRGON vs AMLX, HROW, ANIP: GF Score Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Perrigo Co's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Perrigo Co GF Score vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Perrigo Co's GF Score distribution charts can be found below:
* The bar in red indicates where Perrigo Co's GF Score falls into.
Perrigo Co (MEX:PRGON) has a GF Score of 44 as of Jun. 24, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Perrigo Co and its competitors. This is 31% below median its historical median of 64.00. Over the past decade, Perrigo Co's GF Score has ranged from 22.00 to 80.00.
Is Perrigo Co's GF Score too high?
Perrigo Co's current GF Score of 44 is 31% below median its 10-year median of 64.00. Over the past 10 years, this metric has ranged from a low of 22.00 to a high of 80.00. Overall, Perrigo Co has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Perrigo Co's GF Score compare to AMLX and HROW?
Perrigo Co's GF Score of 44 can be compared against companies in the Drug Manufacturers industry. Historically, Perrigo Co's own GF Score has ranged from 22.00 to 80.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Drug Manufacturers company?
A good GF Score depends on the Drug Manufacturers industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Perrigo Co and its competitors. Perrigo Co's current GF Score is 44, which is 31% below median its own 10-year median of 64.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Perrigo Co stock overvalued right now?
Perrigo Co (MEX:PRGON) has a current GF Score of 44. The stock's GF Value™ is MXN1,468.70, compared to a current price of MXN557.52 — trading 62% below its estimated fair value. The current GF Score is 44, which is 31% below median its 10-year median of 64.00. Perrigo Co's overall GF Score™ is 44/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Perrigo Co (MEX:PRGON), the current GF Score is 44 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Perrigo Co (MEX:PRGON) Overvalued in 2026?
Based on GuruFocus' analysis, Perrigo Co stock appears to be undervalued.
The current stock price of MXN557.52 is trading 62% below its estimated GF Value™ of MXN1,468.70.
Key valuation signals for MEX:PRGON:
GF Score: 44 (31% below median its 10-year median of 64.00)
GF Value™: MXN1,468.70 vs. price of MXN557.52 (62% below fair value)
No single metric tells the full story. See the MEX:PRGON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
44GF Score
Get the complete analysis for MEX:PRGON
GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:PRGON has been successfully added to your 